SCM
Steadfast Capital Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118M | Sell |
1,096,590
-465,056
| -30% | -$50M | 2.1% | 16 |
|
|
2025
Q1 | $158M | Sell |
1,561,646
-816,418
| -34% | -$82.4M | 4.19% | 5 |
|
|
2024
Q4 | $212M | Buy |
2,378,064
+448,879
| +23% | +$40.1M | 4.32% | 3 |
|
|
2024
Q3 | $162M | Sell |
1,929,185
-230,897
| -11% | -$19.3M | 3.59% | 5 |
|
|
2024
Q2 | $166M | Sell |
2,160,082
-153,357
| -7% | -$11.8M | 3.5% | 8 |
|
|
2024
Q1 | $158M | Sell |
2,313,439
-722,600
| -24% | -$49.5M | 3.57% | 8 |
|
|
2023
Q4 | $176M | Buy |
3,036,039
+314,000
| +12% | +$18.2M | 4.33% | 5 |
|
|
2023
Q3 | $144M | Buy |
2,722,039
+637,085
| +31% | +$33.6M | 3.86% | 6 |
|
|
2023
Q2 | $113M | Buy |
2,084,954
+451,029
| +28% | +$24.4M | 3% | 13 |
|
|
2023
Q1 | $81.7M | Sell |
1,633,925
-1,369,511
| -46% | -$68.5M | 2.46% | 16 |
|
|
2022
Q4 | $139M | Buy |
+3,003,436
| New | +$139M | 4.78% | 8 |
|
|
2022
Q2 | – | Sell |
-1,710,408
| Closed | -$75.8M | – | 43 |
|
|
2022
Q1 | $75.8M | Buy |
+1,710,408
| New | +$75.8M | 1.3% | 20 |
|
|
2020
Q4 | – | Sell |
-9,475,750
| Closed | -$362M | – | 55 |
|
|
2020
Q3 | $362M | Buy |
9,475,750
+216,188
| +2% | +$8.26M | 3.96% | 4 |
|
|
2020
Q2 | $325M | Buy |
9,259,562
+5,241,282
| +130% | +$184M | 3.71% | 7 |
|
|
2020
Q1 | $131M | Buy |
+4,018,280
| New | +$131M | 2.01% | 21 |
|